MIST
Milestone Pharmaceuticals
$1.13
−$0.03 (−2.59%)Jul 27, 2026
Key metrics
The numbers that frame MIST today
- Market cap
- $140.68M
- P/E (TTM)
- -2.1
- EV / FCF
- -4.0
- Gross margin
- 99.2%
- EV / Sales
- 115.9
- ROIC
- -52.9%
- Div yield
- 0%
- Debt / equity
- 3.8
- 52wk Low
- $1.00
- 52wk High
- $3.06
Growth
Revenue and earnings trend for MIST
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MIST
Is Milestone Pharmaceuticals a good buy?
No. Milestone Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Milestone Pharmaceuticals is selling at a very high price.
What is the market capitalization of MIST?
Milestone Pharmaceuticals's market capitalization is $140.68M.
What is the P/E ratio for MIST stock?
Milestone Pharmaceuticals's current P/E ratio is -2.1.
What is the 52-week high for MIST stock?
The 52-week high for Milestone Pharmaceuticals is $3.06. The current close of $1.13 is 63.1% below that high.
What is the 52-week low for MIST stock?
The 52-week low for Milestone Pharmaceuticals is $1.00. The current close of $1.13 is 13% above that low.
Does MIST stock pay dividends?
Milestone Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MIST?
Milestone Pharmaceuticals's Debt / Equity ratio is 3.81.